Indications:
Enthesitis-Related Arthritis (ERA)
Cosentyx is indicated for the treatment of active enthesitis-related arthritis in patients 6 years and older whose disease has responded inadequately to, or who cannot tolerate, conventional therapy.
Juvenile Psoriatic Arthritis (JPsA)
Cosentyx is indicated for the treatment of active juvenile psoriatic arthritis in patients 6 years and older whose disease has responded inadequately to, or who cannot tolerate, conventional therapy.
|